Stockscreener 앱 받기
0.2602
0.00%
0.00
시간 외 거래:
.26
-0.0002
-0.08%
전일 마감가:
$0.2602
열려 있는:
$0.31445
하루 거래량:
300.23K
Relative Volume:
0.12
시가총액:
$3.89M
수익:
$17.21M
순이익/손실:
$-23.45M
주가수익비율:
-0.0449
EPS:
-5.7938
순현금흐름:
$-36.90M
1주 성능:
-65.71%
1개월 성능:
-76.35%
6개월 성능:
-88.12%
1년 성능:
-88.93%
1일 변동 폭
$0.257
$0.36
1주일 범위
$0.257
$0.788
52주 변동 폭
$0.257
$4.18
Allurion Technologies Inc Stock (ALUR) Company Profile
Compare ALUR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALUR
Allurion Technologies Inc
|
0.2602 | 10.03M | 17.21M | -23.45M | -36.90M | -5.7938 |
|
ABT
Abbott Laboratories
|
110.25 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
345.78 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.97 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.63 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.09 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-14 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2024-10-02 | 개시 | TD Cowen | Buy |
| 2024-09-06 | 개시 | ROTH MKM | Buy |
| 2024-02-09 | 개시 | Jefferies | Buy |
Allurion Technologies Inc 주식(ALUR)의 최신 뉴스
Weight-loss firm targets 20M ex-GLP-1 users as U.S. launch begins - Stock Titan
Weight Loss Devices Market Poised for Rapid Expansion to USD - openPR.com
Why did Allurion stock surge over 50% today? - MSN
Death Cross: How Allurion Technologies Inc. stock valuations compare to rivalsWeekly Trade Review & Target Return Focused Stock Picks - Naître et grandir
Intercontinental Exchange : NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR) - marketscreener.com
GN Store Nord (OTCMKTS:GNNDY) and Allurion Technologies (NYSE:ALUR) Financial Survey - Defense World
CPUHCompute Health Acquisition Corp. Warrant Holders Hold Special Meeting - ADVFN Ltd
8 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session - Benzinga
NYSE initiates delisting proceedings against Allurion By Investing.com - Investing.com Canada
Allurion Technologies Appeals NYSE Delisting, Plans Compliance Strategy - The Globe and Mail
RTW funds report 39.4% Allurion (ALUR) ownership in 13D amendment - Stock Titan
NYSE initiates delisting proceedings against Allurion - Investing.com
Allurion intends to appeal NYSE notice of delisting, execute plan to regain compliance, and expects to continue trading on NYSE - marketscreener.com
ALLURION TECHNOLOGIES announced that the company plans to formally appeal the delisting notice issued by the New York Stock Exchange. - Bitget
Allurion Technologies Received Notice of Delisting - TradingView
NYSE moves to delist Allurion (NYSE: ALUR) as company plans appeal - Stock Titan
Nyse to commence delisting proceedings against Allurion Technologies, Inc. - marketscreener.com
Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE - Business Wire
NYSE To Commence Delisting Proceedings Against Allurion Technologies, Inc. - TradingView
NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR) - FinancialContent
Allurion Technologies (NYSE:ALUR) & CeriBell (NASDAQ:CBLL) Head-To-Head Survey - Defense World
ALUR Should I Buy - Intellectia AI
Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year? - Yahoo Finance
What's going on with Allurion stock on Wednesday? - MSN
FDA approves Allurion’s gastric balloon system - BioWorld MedTech
Contrasting Allurion Technologies (NYSE:ALUR) and Metastat (OTCMKTS:MTST) - Defense World
What's Going On With Allurion Stock On Wednesday? - Benzinga
Allurion Technologies amends warrant terms and raises $3 million through inducement offer - Investing.com Nigeria
Allurion Technologies Amends Warrants to Bolster Liquidity - TipRanks
Allurion Lowers Warrant Exercise Price to $1.15, Raises ~$3M and Issues 5.32M New Warrants - TradingView
Allurion Technologies (ALUR) secures $3M via warrant repricing and new warrants - Stock Titan
Why Did Allurion Stock Surge Over 50% Today? - Stocktwits
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session - Benzinga
Nasdaq Gains Over 1%; Keurig Dr Pepper Earnings Top Views - Benzinga
Chardan Capital Upgrades Allurion Technologies (ALUR) - Nasdaq
Strategic Acquisition Amplifies Allurion’s Market Presence - StocksToTrade
Dow Gains Over 100 Points; Home Depot Posts Upbeat Earnings - Benzinga
Allurion Technologies upgraded to Buy from Neutral at Chardan - TipRanks
Allurion Technologies stock rating upgraded on FDA approval By Investing.com - Investing.com India
Allurion stock balloons as FDA signs off on weight loss device - Fierce Biotech
ALUR Sees Market Volatility Amidst Strategic Moves and Market Challenges - timothysykes.com
Allurion Technologies stock rating upgraded on FDA approval - Investing.com UK
Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds - Business Wire
Chardan Upgrades Allurion Technologies to Buy From Neutral, $3 Price Target - marketscreener.com
Earnings Recap: Is KOPN in a bullish channelJuly 2025 Market Mood & Accurate Buy Signal Alerts - baoquankhu1.vn
U.S. Stocks Mixed in Morning Trade; Dow Jones Up Over 100 Points - Intellectia AI
FDA approves Allurion gastric balloon for obesity treatment By Investing.com - Investing.com Australia
FDA Approves Swallowable Balloon for Weight Loss. How Does It Compare to GLP-1 Drugs? - TODAY.com
Dow Tumbles Over 700 Points; Dominion Energy Posts Upbeat Earnings - Benzinga
Allurion Wins FDA Nod for Alternative to GLP-1s - Medical Device and Diagnostic industry
12 Consumer Discretionary Stocks Moving In Monday's Intraday Session - Benzinga
Allurion Technologies Inc (ALUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.21%
0.24%
자본화:
|
볼륨(24시간):